Trial Profile
Surgical Coronary Revascularization Outcomes After Oral Anticoagulation or Antiplatelet Strategies
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Jan 2021
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Aspirin
- Indications Thromboembolism
- Focus Adverse reactions; Therapeutic Use
- Acronyms SCOOP
- 06 Aug 2018 New trial record